Scribe Therapeutics, Inc.
SCTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001853921
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 20269:20 PM ET | Jul 23, 2026 | Parrot DavidChief Financial Officer | PPurchaseCommon Stock | +2.67K | $15.00 | +$39.99K | 1.33K | New position | SEC |
| Jul 27, 20269:42 PM ET | Jul 23, 2026 | Lucas SvetlanaChief Business Officer | PPurchaseCommon Stock | +3K | $15.00 | +$45K | 3K | New position | SEC |
| Jul 28, 20269:30 PM ET | Jul 24 – Jul 28, 2026 | Avoro Capital Advisors LLC and 2 othersDirector, 10% Owner, Other: See Remarks | PPurchaseCommon Stock, par value $0.0001 per share | +2.39M | $15.1636 | +$36.26M | 3.09M | +342.8% | SEC |
| Jul 29, 20266:47 PM ET | Jul 27, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | PPurchaseCommon Stock | +1M | $15.00 | +$15M | 1.35M | +286.7% | SEC |
| Jul 29, 20266:50 PM ET | Jul 27, 2026 | GORDON CARL LDirector | PPurchaseCommon Stock | +1M | $15.00 | +$15M | 1.35M | +286.7% | SEC |
| Jul 29, 20267:09 PM ET | Jul 27, 2026 | Andreessen Marc L and 5 others10% Owner | PPurchaseCommon Stock | +333.33K | $15.00 | +$5M | 2.39M | +16.2% | SEC |